AM Rx vs PlushCare
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AM Rx
Best for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully)Starting at $25/mo
PlushCare
Best for readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribingStarting at $149/mo
Side-by-Side Comparison
| Feature | AM Rx | PlushCare |
|---|---|---|
| Overall Score | 5.9/10 | ✓7.0/10 |
| Starting Price | ✓$25/mo | $149/mo |
| Editorial Rating | 3 ★ /5 | ✓3.5 ★ /5 |
| Features | 6 features | ✓7 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 2 warnings | ✓None |
Pros & Cons
AM Rx
Pros
- ✓Insurance coordination for brand-name GLP-1s — as low as $25/mo
- ✓All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- ✓HSA and FSA accepted
- ✓Video visits available (not just async) with providers averaging 10+ years experience
- ✓Compounded semaglutide from $151/mo quarterly
Cons
- ✗Active FTC/DOJ lawsuit for deceptive billing and subscription practices (ROSCA violations)
- ✗Two FDA warning letters (Sept 2025, Feb 2026) for misbranding compounded GLP-1 products
- ✗Novo Nordisk false advertising lawsuit (Aug 2025)
- ✗Parent entity Zealthy has BBB D- rating with 2,370+ complaints
- ✗Trustpilot 2.0/5 — 85% one-star reviews citing billing disputes and unreachable support
- ✗No visible LegitScript certification or PCAB accreditation
- ✗No named pharmacy partners — compounding source not disclosed
- ✗No FDA compounding disclaimer on the website
- ✗State availability not publicly disclosed
- ✗Founder Kyle Robertson previously ran Cerebral, which settled FTC charges for similar practices
- ✗Same corporate entity (FitRX LLC) as Zealthy and FitRx — shares regulatory history
PlushCare
Pros
- ✓All 50 states per the homepage
- ✓Appointments with US board-certified physicians (not nurse practitioners only)
- ✓Operates as virtual primary care, so the same provider can write GLP-1 prescriptions alongside other primary-care needs
- ✓Owned by Transcarent (post-Accolade-acquisition), a venture-backed health platform with named corporate parent
Cons
- ✗ACTIVE LITIGATION: California class action alleging deceptive subscription enrollment and unauthorized post-cancellation charges on the $19.99/month membership. Material disclosure for any reader signing up.
- ✗GLP-1 prescribing is clinician-discretionary at the visit level — not a guaranteed offering at intake
- ✗BBB rating reflects an ongoing pattern of complaints around the membership cancellation flow
Our Verdict
PlushCare edges out AM Rx with a higher overall score of 7.0/10 and is particularly strong for readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribing. AM Rx remains a solid alternative, especially if you're looking for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.